Express News | Qinghai Spring: Deferred disclosure of the 2023 Annual Report and the 2024 First Quarter Report until April 30, 2024

BreakingsApr 22 18:02

Qinghai Spring Medicinal Resources Technology Plans Shares Buyback of Up to 50 Million Yuan

Qinghai Spring Medicinal Resources Technology (SHA:600381) plans to repurchase shares amounting between 30 million yuan and 50 million yuan, according to the company's filing on the Shanghai Stock Exc

MT NewswiresApr 19 13:51

Express News | Qinghai Spring: Plans to repurchase shares for 30 million yuan to 50 million yuan

BreakingsApr 18 18:36

Qinghai Spring Medicinal Resources Technology (SHSE:600381 Investor One-year Losses Grow to 56% as the Stock Sheds CN¥476m This Past Week

Taking the occasional loss comes part and parcel with investing on the stock market. And unfortunately for Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHSE:600381) shareholders, the stoc

Simply Wall StApr 18 08:49

The majority shareholder of Tsinghua Liquor was classified as an abnormal business

Gelonghui, March 19 | According to Tianyan Research, Chengdu Jiuyixing Biotechnology Co., Ltd. was included in the list of business anomalies by the Chengdu High-tech Zone Market Supervision Administration because the registered residence or place of business could not be contacted. The company was founded in December 2021. The legal representative is Li Rongquan, with a registered capital of 1 million yuan. Li Rongquan and Lin Xiaoli are jointly owned by Li Rongquan and Lin Xiaoli. According to foreign investment information, the company is the largest shareholder of Yibin Tinghua Liquor Development Co., Ltd., holding 95% of the shares. According to media reports, the CCTV March 15 gala revealed the issue of listening to false publicity about Huaju, suspected of violating advertising laws, and was later exposed at the gala.

Gelonghui FinanceMar 19 15:39

Qinghai Spring Medicinal Resources Probed Over Misleading Ad for Rice Wine

The Shanghai Stock Exchange asked Chinese health company Qinghai Spring Medicinal Resources Technology (SHA:600381) to explain reports of misleading advertising, according to a March 15 filing publish

MT NewswiresMar 19 14:54